Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christina Prucker"'
Autor:
Andreas Peyrl, Maria-Theresa Schmook, Amedeo A. Azizi, Irene Slavc, Mark W. Kieran, Karin Dieckmann, Christine Haberler, Christina Prucker, Thomas Czech, Ulrike Leiss, Monika Chocholous
Publikováno v:
Pediatric Blood & Cancer. 59:511-517
Background Median survival time of recurrent embryonal brain tumors is short regardless of salvage chemotherapy used. An evolving alternative approach to conventional chemotherapy is to target neovascularization by interfering with tumor angiogenesis
Autor:
Diethart Schmid, Miriam Gruber, Florian Woehs, Sonja Prinz, Barbara Etzlstorfer, Christina Prucker, Nicola Fuzzati, Brigitte Kopp, Thomas Moeslinger
Publikováno v:
Journal of Pharmacy and Pharmacology. 61:1089-1096
Autor:
Thomas Moeslinger, Diethart Schmid, Sonja Prinz, Florian Woehs, Nicola Fuzzati, Barbara Etzlstorfer, Christina Prucker, Brigitte Kopp, Miriam Gruber
Publikováno v:
Journal of Pharmacy and Pharmacology. 61:1089-1096
Objectives Cimicifuga racemosa (Actaea racemosa, black cohosh) is used as an anti-inflammatory, antipyretic and analgesic remedy in traditional medicines. The present study focuses on the effects of C. racemosa root extracts on inducible nitric oxide
Autor:
Andreas Peyrl, Irene Slavc, Ulrike Leiss, Christine Haberler, Maria-Theresa Schmook, Monika Chocholous, Amedeo A. Azizi, Mark W. Kieran, Thomas Czech, Christina Prucker, Karin Dieckmann
Publikováno v:
memo - Magazine of European Medical Oncology. 4:21-23
Children with relapsed malignant brain tumours have a poor prognosis despite intensive treatment including high-dose chemotherapy with stem cell rescue [1, 2]. Angiogenesis, the formation of new blood vessels, is an important component of normal phys
Autor:
Andreas, Peyrl, Monika, Chocholous, Mark W, Kieran, Amedeo A, Azizi, Christina, Prucker, Thomas, Czech, Karin, Dieckmann, Maria-Theresa, Schmook, Christine, Haberler, Ulrike, Leiss, Irene, Slavc
Publikováno v:
Pediatric bloodcancer. 59(3)
Median survival time of recurrent embryonal brain tumors is short regardless of salvage chemotherapy used. An evolving alternative approach to conventional chemotherapy is to target neovascularization by interfering with tumor angiogenesis at various